Background Hybrid coronary revascularization?HCR?and off-pump coronary artery bypass grafting?OPCABG?are both considered to be safe,feasible,less invasive techniques for coronary revascularization.While both procedures utilize the left internal mammary artery?LIMA?to left anterior descending artery?LAD?graft,HCR selects drug-eluting stents?DES?instead of saphenous vein bypass.It remains unclear whether HCR is equal to,better or worse than OPCABG.Methods and Results Meta-analysis was conducted using a random effects model.Seven observational studies were included.There was no significant difference either in in-hospital Mortality?RR 0.57,95%CI 0.13-2.59,p=0.47?or in MACCE rate?RR 0.63,95%CI 0.24-1.64,p=0.34?between the HCR group and the OPCABG group.Significant difference was observed between the two groups in the length of hospitalization?RR 0.55,95%CI 0.13-0.97,p=0.01?,length of ICU stay?RR 045,95%CI 0.10-0.80,p<0.05?,intubation time?RR 0.48,95%CI 0.13-0.84,p<0.01?,need for red blood transfusion?RR 0.67,95%CI 0.56-0.82,p<0.001?,and total in-hospital costs?RR 0.90,95%CI 0.39-1.42,p<0.01?.Conclusions Compared with OPCABG,HCR did not improve early survival but decreased the length of hospitalization,length of ICU stay,intubation time,need for red blood transfusion,and increased total in-hospital costs?... |